Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancerDe‐Shen Wang, Yuhong Li, Gong Chen et al.|Cancer Medicine|2019Cited by 28